AAAAAA

   
Results: 1-18 |
Results: 18
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility
Authors: Snapper, SB Takeshima, F Anton, I Liu, CH Thomas, SM Nguyen, D Dudley, D Fraser, H Purich, D Lopez-Ilasaca, M Klein, C Davidson, L Bronson, R Mulligan, RC Southwick, F Geha, R Goldberg, MB Rosen, FS Hartwig, JH Alt, FW
Citation: Sb. Snapper et al., N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility, NAT CELL BI, 3(10), 2001, pp. 897-904
Direct delivery of leptin to the hypothalamus using recombinant adeno-associated virus vectors results in increased therapeutic efficacy
Authors: Lundberg, C Jungles, SJ Mulligan, RC
Citation: C. Lundberg et al., Direct delivery of leptin to the hypothalamus using recombinant adeno-associated virus vectors results in increased therapeutic efficacy, NAT BIOTECH, 19(2), 2001, pp. 169-172
Plasmid DNA encapsulation and release from solvent diffusion nanospheres
Authors: Hirosue, S Muller, BG Mulligan, RC Langer, R
Citation: S. Hirosue et al., Plasmid DNA encapsulation and release from solvent diffusion nanospheres, J CONTR REL, 70(1-2), 2001, pp. 231-242
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
Authors: Kuo, CJ Farnebo, F Yu, EY Christofferson, R Swearingen, RA Carter, R von Recum, HA Yuan, J Kamihara, J Flynn, E D'Amato, R Folkman, J Mulligan, RC
Citation: Cj. Kuo et al., Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer, P NAS US, 98(8), 2001, pp. 4605-4610
Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein
Authors: Snitkovsky, S Niederman, TMJ Mulligan, RC Young, JAT
Citation: S. Snitkovsky et al., Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein, J VIROLOGY, 75(3), 2001, pp. 1571-1575
Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain
Authors: Kuo, CJ LaMontagne, KR Garcia-Cardena, G Ackley, BD Kalman, D Park, S Christofferson, R Kamihara, J Ding, YH Lo, KW Gillies, S Folkman, J Mulligan, RC Javaherian, K
Citation: Cj. Kuo et al., Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain, J CELL BIOL, 152(6), 2001, pp. 1233-1246
Glucose-induced toxicity in insulin-producing pituitary cells that coexpress GLUT2 and glucokinase - Implications for metabolic engineering
Authors: Faradji, RN Havari, E Chen, Q Gray, J Tornheim, K Corkey, BE Mulligan, RC Lipes, MA
Citation: Rn. Faradji et al., Glucose-induced toxicity in insulin-producing pituitary cells that coexpress GLUT2 and glucokinase - Implications for metabolic engineering, J BIOL CHEM, 276(39), 2001, pp. 36695-36702
Bryophyte community structure in a boreal poor fen: reciprocal transplants
Authors: Mulligan, RC Gignac, LD
Citation: Rc. Mulligan et Ld. Gignac, Bryophyte community structure in a boreal poor fen: reciprocal transplants, CAN J BOTAN, 79(4), 2001, pp. 404-411
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
Authors: Nelson, WG Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Kim, M Weber, CE Baccala, AA Goeman, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF
Citation: Wg. Nelson et al., Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies, CANC CHEMOT, 46, 2000, pp. S67-S72
Heterogeneity of the angiogenic response induced in different normal adulttissues by vascular permeability factor/vascular endothelial growth factor
Authors: Pettersson, A Nagy, JA Brown, LF Sundberg, C Morgan, E Jungles, S Carter, R Krieger, JE Manseau, EJ Harvey, VS Eckelhoefer, IA Feng, D Dvorak, AM Mulligan, RC Dvorak, HF
Citation: A. Pettersson et al., Heterogeneity of the angiogenic response induced in different normal adulttissues by vascular permeability factor/vascular endothelial growth factor, LAB INV, 80(1), 2000, pp. 99-115
A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor
Authors: Snitkovsky, S Niederman, TMJ Carter, BS Mulligan, RC Young, JAT
Citation: S. Snitkovsky et al., A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor, J VIROLOGY, 74(20), 2000, pp. 9540-9545
Expression of Bcl-X-L restores cell survival, but not proliferation and effector differentiation, in CD28-deficient T lymphocytes
Authors: Dahl, AM Klein, C Andres, PG London, CA Lodge, MP Mulligan, RC Abbas, AK
Citation: Am. Dahl et al., Expression of Bcl-X-L restores cell survival, but not proliferation and effector differentiation, in CD28-deficient T lymphocytes, J EXP MED, 191(12), 2000, pp. 2031-2037
Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines
Authors: Klein, C Bueler, H Mulligan, RC
Citation: C. Klein et al., Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines, J EXP MED, 191(10), 2000, pp. 1699-1708
Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood
Authors: Storms, RW Goodell, MA Fisher, A Mulligan, RC Smith, C
Citation: Rw. Storms et al., Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood, BLOOD, 96(6), 2000, pp. 2125-2133
Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig
Authors: Feng, S Quickel, RR Hollister-Lock, J McLeod, M Bonner-Weir, S Mulligan, RC Weir, GC
Citation: S. Feng et al., Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig, TRANSPLANT, 67(12), 1999, pp. 1607-1613
Dystrophin expression in the mdx mouse restored by stem cell transplantation
Authors: Gussoni, E Soneoka, Y Strickland, CD Buzney, EA Khan, MK Flint, AF Kunkel, LM Mulligan, RC
Citation: E. Gussoni et al., Dystrophin expression in the mdx mouse restored by stem cell transplantation, NATURE, 401(6751), 1999, pp. 390-394
Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
Authors: Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Lim, M Weber, CE Baccala, AA Goemann, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF Nelson, WG
Citation: Jw. Simons et al., Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer, CANCER RES, 59(20), 1999, pp. 5160-5168
One-day ex vivo culture allows effective gene transfer into human nonobesediabetic severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus
Authors: Rebel, VI Tanaka, M Lee, JS Hartnett, S Pulsipher, M Nathan, DG Mulligan, RC Sieff, CA
Citation: Vi. Rebel et al., One-day ex vivo culture allows effective gene transfer into human nonobesediabetic severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus, BLOOD, 93(7), 1999, pp. 2217-2224
Risultati: 1-18 |